Google Health’s AI tool slashes abnormal chest X-ray turnaround times by 28% The Palo Alto giant used exams from nearly 250,000 patients to upgrade its already robust algorithm.Read more about Google Health’s AI tool slashes abnormal chest X-ray turnaround times by 28%
‘Practice changing’: New research underscores clinical benefits of PSMA-PET for prostate cancer California nuclear medicine experts said the technology will ultimately become part of routine staging for the disease, publishing their study findings in JAMA Oncology.Read more about ‘Practice changing’: New research underscores clinical benefits of PSMA-PET for prostate cancer
Virtual interview format may become new normal for radiology residency match season Residents who participated in the inaugural 2020-2021 online process analyzed the benefits and downsides.Read more about Virtual interview format may become new normal for radiology residency match season
Pairing faster imaging sequence with deep learning cuts shoulder MRI scan time by 67% Exams performed using the deep learning-based reconstruction tool also maintained high image quality, experts reported recently.Read more about Pairing faster imaging sequence with deep learning cuts shoulder MRI scan time by 67%
Medtech company Us2.ai gains FDA clearance for automated echocardiography software The news comes following a validation study at Brigham and Women's Hospital and multiple trials with pharmaceutical partners.Read more about Medtech company Us2.ai gains FDA clearance for automated echocardiography software
Docs say recall disagreements between top breast imaging techniques require further scrutiny University of Texas MD Anderson Cancer Center experts believe the differences could have an impact on cancer detection.Read more about Docs say recall disagreements between top breast imaging techniques require further scrutiny
New data show ‘unequivocal support’ for LDCT screening patients at risk of lung cancer Despite Medicare funding LDCT screening programs in the U.S., experts say uptake remains low, at around 4%.Read more about New data show ‘unequivocal support’ for LDCT screening patients at risk of lung cancer
National cancer network adds PSMA-PET agents to new prostate imaging guidelines National Comprehensive Cancer Network recommendations are widely recognized by providers and payers as the standard for clinical policy in oncology.Read more about National cancer network adds PSMA-PET agents to new prostate imaging guidelines
Radiology department automates process for spotting reports with actionable findings The novel natural language processing technique can pinpoint overlooked details and avoid costly delays to patient care.Read more about Radiology department automates process for spotting reports with actionable findings
New PET imaging agent alters prostate cancer plan for more than 40% of patients Lantheus recently presented early results from the OSPREY trial during the American Urological Association's virtual meeting.Read more about New PET imaging agent alters prostate cancer plan for more than 40% of patients
